4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001104659-15-081130
Director acquired 3,502 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saad Mark E Director | 2015-11-24 | Conversion | +3,502 | $5.94 | $20,802 | 3,502 | D |
| Derivatives | |||||||
| Saad Mark E Director | 2015-11-24 | Grant or award · 8% Convertible Note | +3,502 | 0 | D | ||
Loading xslF345X03/a4.xml…